Independent Portfolio Consultants’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-14
Closed 956
2016
Q4
$0 Buy
+14
New ﹤0.01% 882
2016
Q2
Sell
-5,095
Closed -$114K 797
2016
Q1
$114K Buy
5,095
+125
+3% +$2.8K 0.03% 453
2015
Q4
$137K Buy
4,970
+1,010
+26% +$27.8K 0.04% 396
2015
Q3
$102K Sell
3,960
-265
-6% -$6.83K 0.02% 453
2015
Q2
$105K Buy
4,225
+1,895
+81% +$47.1K 0.02% 496
2015
Q1
$59K Buy
2,330
+50
+2% +$1.27K 0.01% 591
2014
Q4
$53K Buy
2,280
+830
+57% +$19.3K 0.01% 628
2014
Q3
$33K Buy
+1,450
New +$33K 0.01% 669

Other funds holding QGENF

Independent Portfolio Consultants's QGENF Position: Q1 2017 in Review

Independent Portfolio Consultants sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 14 shares.

Independent Portfolio Consultants first reported a position in QGENF in Q3 2014 and held it in 8 quarters. The position peaked at $137K in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Independent Portfolio Consultants reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Independent Portfolio Consultants sold 14 QIAGEN NV shares in Q1 2017.
  • Independent Portfolio Consultants first reported a position in QIAGEN NV in Q3 2014 and held it in 8 quarters.
  • Independent Portfolio Consultants's QIAGEN NV position peaked at $137K in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Independent Portfolio Consultants's 13F filing for Q1 2017, filed 25 Apr 2017.